The U.S. Food and Drug Administration (FDA) announced that an emergency use authorization (EUA) had been granted to the DOD on July 9, 2018, enabling the emergency use of French-manufactured Freeze-Dried Plasma (FFDP) for treatment of hemorrhage or coagulopathy involving agents of military combat (e.g., firearms, projectiles, and explosive devices). At this time, this EUA only applies to the use of the French-manufactured plasma, which significantly limits the amount of product available to the Armed Services Blood Program.
The volume of product available and the requirement for training and regulatory compliance under the EUA for use of the product greatly restrict our current ability to field this product across the DOD, allowing only limited distribution of the product as a force health protection investigational product. However, ongoing efforts to develop an American-manufactured freeze-dried plasma product continue, with an estimated time-frame of FDA approval in early 2019. Once the American-manufactured product becomes FDA approved, it will provide the DOD with a greater capacity to field a needed blood product.
For more information on this FFDP EUA and related documents:
You also may be interested in...
Article Around MHS
7/14/2022
Army Garrison Fort Hunter Liggett’s remoteness, and the robust efforts of Fire Captain Devon Haggie allowed the installation to be the first in the Army and Department of Defense to receive the life-saving capability to transfuse whole blood by its Emergency Medical Service (EMS).
Video
3/23/2017
Hemorrhage is responsible for 91.5 percent of potentially survivable battlefield deaths. From 2001 to 2011, an estimated 24 percent of combat deaths occurred before patients reached a treatment facility; the major cause of death was blood loss. Battlefield trauma innovations like the occlusion balloon catheter and freeze-dried plasma will enhance the Joint Forces' current capabilities.
Page 1 of 1
, showing items 1 - 2
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: January 10, 2023